Elanix Biotechnologies
Elanix Biotechnologies is a tissue regeneration company. We develop and commercialize products for acute wound care, dermatological and gynecological applications, as well as providing cell technology services. The company was founded in 2013 as a spin-out from the University Hospital of Lausanne (CHUV), Switzerland, to commercialize a patented progenitor cell technology. Progenitor cells are fully differentiated yet immunologically neutral cells that are very potent inducers of tissue growth and healing. Elanix owns GMP certified Master and Working cell banks containing vast quantities of cells. The Company is headquartered in Nyon, Switzerland with offices in Wiesbaden and listed on the Frankfurt stock exchange under the symbol ELN.
Industries
Nr. of Employees
small (1-50)
Elanix Biotechnologies
Products
Regenerative Skin Solutions
A skin care product line designed to support healing and skin regeneration after medical procedures.
Orthopedic Regeneration
Therapies aimed at treating orthopedic injuries and conditions to promote recovery without invasive surgery.
Cardiovascular Therapies
Therapies developed to repair and regenerate heart tissue following injury or disease.
Custom Cellular Therapies
Personalized stem cell-based treatments tailored to individual patient needs for various conditions.
Regenerative Skin Solutions
A skin care product line designed to support healing and skin regeneration after medical procedures.
Orthopedic Regeneration
Therapies aimed at treating orthopedic injuries and conditions to promote recovery without invasive surgery.
Cardiovascular Therapies
Therapies developed to repair and regenerate heart tissue following injury or disease.
Custom Cellular Therapies
Personalized stem cell-based treatments tailored to individual patient needs for various conditions.